Aspiriant LLC’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,178
Closed -$211K 272
2022
Q2
$211K Buy
1,178
+24
+2% +$6.13K 0.01% 260
2022
Q1
$392K Sell
1,154
-15
-1% -$5.07K 0.02% 197
2021
Q4
$433K Buy
1,169
+11
+0.9% +$4.17K 0.02% 187
2021
Q3
$455K Hold
1,158
0.03% 167
2021
Q2
$532K Buy
+1,158
New +$466K 0.03% 151
2020
Q3
Sell
-1,788
Closed -$644K 218
2020
Q2
$644K Hold
1,788
0.06% 113
2020
Q1
$475K Hold
1,788
0.05% 129
2019
Q4
$577K Hold
1,788
0.05% 125
2019
Q3
$529K Buy
1,788
+57
+3% +$16.8K 0.05% 144
2019
Q2
$620K Buy
1,731
+105
+6% +$33.2K 0.05% 134
2019
Q1
$492K Sell
1,626
-380
-19% -$111K 0.04% 145
2018
Q4
$585K Sell
2,006
-294
-13% -$91.1K 0.04% 136
2018
Q3
$820K Sell
2,300
-99
-4% -$31.7K 0.07% 119
2018
Q2
$652K Buy
2,399
+40
+2% +$10.2K 0.06% 140
2018
Q1
$543K Buy
+2,359
New +$541K 0.05% 148
2017
Q4
Sell
-2,413
Closed -$468K 127
2017
Q3
$468K Buy
2,413
+784
+48% +$146K 0.04% 142
2017
Q2
$275K Buy
+1,629
New +$282K 0.02% 178

Other funds holding ILMN

Aspiriant LLC's ILMN Position: Q3 2022 in Review

Aspiriant LLC sold out of Illumina (ILMN) in Q3 2022, closing a stake of 1,178 shares — an estimated $211K sold.

Aspiriant LLC first reported a position in ILMN in Q2 2017 and held it in 17 quarters. The position peaked at $820K in Q3 2018. 897 funds tracked by Wall St. Rank hold ILMN as of Q3 2022.

  • Aspiriant LLC reported no remaining Illumina position as of Q3 2022 after selling out during the quarter.
  • Aspiriant LLC sold 1,178 Illumina shares in Q3 2022, an estimated $211K.
  • Aspiriant LLC first reported a position in Illumina in Q2 2017 and held it in 17 quarters.
  • Aspiriant LLC's Illumina position peaked at $820K in Q3 2018.
  • 897 funds tracked by Wall St. Rank held Illumina as of Q3 2022.

Based on Aspiriant LLC's 13F filing for Q3 2022, filed 28 Oct 2022.